Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Vistagen Therapeutics, Inc. (VTGN)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
7 Aug 2023
COMMODORE CAPITAL LP
10% Owner
Vistagen Therapeutics, Inc.
(VTGN)
1,575,000
+97%
775,756
$23.15
$17,961,078.00
BUY
18 Aug 2022
GIN JERRY B
Director
VistaGen Therapeutics, Inc.
(VTGN)
100,000
+200%
200,000
$0.18
$35,740.00
BUY
17 Aug 2022
Singh Shawn
CHIEF EXECUTIVE OFFICER, Director, Officer
VistaGen Therapeutics, Inc.
(VTGN)
626,234
+2287%
600,000
$0.17
$103,200.00
BUY
17 Aug 2022
Adler Reid G.
CHIEF LEGAL OFFICER, Officer
VistaGen Therapeutics, Inc.
(VTGN)
334,629
+866%
300,000
$0.17
$50,910.00
SELL
12 Jul 2022
Venrock Healthcare Capital Partners II, L.P.
10% Owner
VistaGen Therapeutics, Inc.
(VTGN)
20,637,286
-0%
60,000
$0.89
$53,400.00
SELL
7 Sep 2021
DOTSON JERROLD DUANE
VP, CFO AND SECRETARY, Officer
VistaGen Therapeutics, Inc.
(VTGN)
72,786
-29%
30,000
$3.13
$93,750.00
BUY
17 Aug 2021
SNODGRASS H. RALPH
PRES./CHIEF SCIENTIFIC OFFICER, Officer
VistaGen Therapeutics, Inc.
(VTGN)
34,641
+12%
3,750
$2.73
$10,237.50
BUY
21 Aug 2020
SAXE JON S
Director
VistaGen Therapeutics, Inc.
(VTGN)
50,000
+150%
30,000
$0.69
$20,700.00
BUY
20 Nov 2019
SNODGRASS H. RALPH
PRES./CHIEF SCIENTIFIC OFFICER, Director, Officer
VistaGen Therapeutics, Inc.
(VTGN)
15,000
+100%
15,000
$0.34
$5,100.00
BUY
13 Mar 2019
SAXE JON S
Director
VistaGen Therapeutics, Inc.
(VTGN)
20,000
+100%
20,000
$1.26
$25,287.59
Home